Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Pankratz Karin Brigitte |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Kühberger, S; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A;
A Liquid biopsy multi-analyte approach deciphering treatment resistance in prostate cancer supported by machine learning
EACR Liquid Biopsy; NOV 12-14, 2024; Lyon, FRANCE. 2024.
[Poster]
Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A;
Longitudinal tracking of drug resistance in metastatic prostate cancer
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024.
[Poster]
Müller, CT; Escriva Conde, M; Marco Salas, S; Sallinger K; Kühberger, S; Scheiber, M; Bonstingl, L; Pankratz, K; Gruber, M; Schuch, K; Kroneis, T; Uranitsch, S; Mitteregger, M; Aigner, F; Lax, SF; Nilsson, M; Heitzer E; El-Heliebi, A;
Mapping Mutations in Space: Unraveling the Spatial Dynamics of Point Mutations in Colon Cancer
European Society for Spatial Biology; DEC 12-13, 2024; Berlin, GERMANY. 2024.
[Poster]
Sallinger, K; Gruber, M; Müller, C; Bonstingl, L; Pritz, E; Pankratz, K; Gerger, A; Smolle, MA; Aigelsreiter, A; Surova, O; Svedlund, J; Nilsson, M; Kroneis, T; El-Heliebi, A
Imaging-based spatial transcriptomics technology identifies predictive biomarkers for relapse in colon cancer stage II.
MOL BIOL CELL. 2024; 35(1): 618-618.
Web of Science
Benezeder, T; Woltsche, J; Bordag, N; Teufelberger, A; Perchthaler, I; Weger, W; Gruber-Wackernagl, A; Salmhofer, W; Painsi, C; Pankratz, K; El-Heliebi, A; Babina, M; Clark, R; Wolf, P
Mast cells as potential drivers of inflammation in psoriasis
J INVEST DERMATOL. 2023; 143(11):S342-S342.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Characterization of circulating tumor cells by combinatorial dual-color (CoDuCo) in situ padlock probe hybridization and supervised machine-learning.
Applications of In Situ Hybridisation and Spatial Profiling Methods in Research and Disease; MAY 16-17, 2023; Cambridge, UK. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
CTC characterization by multiplex mRNA in situ hybridization and machine learning-assisted classification for longitudinal monitoring of drug resistance in metastatic prostate cancer.
6th ACTC Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Zinnegger, M; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Herbsthofer, L; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Spotting the difference: rare cell characterization by multiplex mRNA in situ hybridization and machine learning in the context of liquid biopsy-based therapy resistance monitoring.
13th International Symposium on Minimal Residual Cancer ISMRC; MAY 2-4, 2023; Hamburg, GERMANY. 2023.
[Poster]
Bonstingl, L; Sallinger, K; Zinnegger, M; Skofler, C; Ulz, C; Pankratz, K; Pritz, E; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Bauernhofer, T; Kroneis, T; El-Heliebi, A
Tracking drug resistance in metastatic prostate cancer: longitudinal CTC characterization using multiplex mRNA in situ hybridization and machine learning-assisted classification.
General Assembly of the European Liquid Biopsy Society ELBS; NOV 9-10, 2023; Rome, ITALY. 2023.
[Oral Communication]
Sallinger, K; Müller, CT; Gruber, MC; Bonstingl, L; Pankratz, K; Kroneis, T; Bramreiter, B; Slaats, E; Schönberger, J; Schuch, K; Rebernig, H; Kirchmayr, M; Tiesmeyer, S; Ishaque, N; El-Heliebi, A
Imaging-based spatial transcriptomics technology identifies predictive biomarkers for relapse in colon cancer stage II
CellBio 2023; DEC 2-6, 2023; Boston, USA. 2023.
[Poster]
Gruber, M; Bonstingl, L; Sallinger, K; Pankratz, K; El-Heliebi, A; Kroneis, T
Challenges in the analysis of rare cells – preparing for microchimerism analysis
International Society of Evolution, Medicine and Public Health - 7th Annual Meeting; JUL 5-8, 2022; Lisbon, PORTUGAL. 2022.
[Oral Communication]
Gruber, MC; Sallinger, K; Bonstingl, L; Slaats, E; Müller, C; Sedik, S; Schuch, K; Schönberger, J; Pankratz, K; El-Heliebi, A; Kroneis, T
On the Phenomenon of Microchimerism
GSRC Seminar Series; OCT 28, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Gruber, MC; Sallinger, K; Bonstingl, L; Slaats, E; Müller, C; Sedik, S; Schuch, K; Schönberger, J; Pankratz, K; El-Heliebi, A; Kroneis, T
Microchimerism or How Some of Us Manage to Live Across Three Generations
Guest Lecture LBI for Lung Vascular Research; NOV 8, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Oberauner-Wappis, L; Pritz, E; Pankratz, K; Kroneis, T; El-Heliebi, A
A novel workflow to enumerate circulating tumor cells by multiplex in situ padlock probe technology and machine learning-based classification.
EACR Virtual Conference Bioinformatics in Cancer; MAY 18-19, 2021; Nottingham, UK. 2021.
[Poster]
Bonstingl, L; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Gruber, MC; Kroneis, T; El-Heliebi, A
Enumerating circulating tumor cells by multiplex in situ padlock probe technology and machine learning-based classification.
5th ACTC - Advances in Circulating Tumor Cells - Liquid Biopsy in its best; SEP 22-25, 2021; Kalamata, GREECE. 2021.
[Poster]
Sallinger, K; Bonstingl, L; Pritz, E; Pankratz, K; Kühberger, S; Heitzer, E; Kroneis, T; El-Heliebi, A
Establishment of the in situ sequencing method to investigate the source of circulating tumor cells and circulating tumor DNA.
Advances in Circulating Tumor Cells - ACTC 2021; SEP 22-25, 2021; Kalamata, Greece. 2021.
[Poster]